Although GLP-1 medications have been around for decades as diabetes drugs, they have only recently been approved for weight loss by the Federal Drug Administration (FDA), and thats what has led to a significant increase in popularity and a rise in microdosing them
The original GLP-1 receptor agonist was exenatide, which was first synthesised in 1996
These are often not caused by the medication itself, but by changes in your lifestyle
LAURA: Como es una pluma nueva, necesito comprobar el flujo
Clinical Takeaways As the prevalence of obesity, insulin resistance, metabolic syndrome and associated health complications continue to rise, targeting GLP-1 activity has emerged as a promising strategy in improving cardiometabolic health and encouraging sustainable weight loss
After 6 weeks, potency may decline even if the medication appears normal